Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest, Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. In this podcast, we discuss the potential impact of the International Pricing Index (IPI) on global innovation, as well as several alternatives which could be put in place that would create less havoc for innovators and patients. As well, we discuss the increasing divergence of the innovative capacity between the US and Europe, and how the current systems of reimbursement are impacting the ability to support and R&D ecosystem.See omnystudio.com/listener for privacy information.